Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Introduction — The Great GLP-1 Transition of 2026
The metabolic health landscape has undergone a monumental shift in 2026. For years, the direct-to-consumer (DTC) telehealth market was dominated by compounded formulations of popular weight-loss medications like semaglutide and tirzepatide. However, a series of high-profile legal settlements, combined with stabilizing drug supply chains and decisive FDA regulatory enforcement, has permanently altered how Americans access these therapies. The era of the unregulated, off-brand “copycat” clinic is rapidly closing, forcing major health tech platforms to adapt.
In a historic development in March 2026, Novo Nordisk and Hims & Hers Health, Inc. settled their outstanding patent litigation. Hims & Hers agreed to completely phase out the mass marketing of compounded semaglutide. In return, they established a strategic partnership to act as an authorized distribution partner for branded, FDA-approved Wegovy injections and the newly launched Wegovy oral pill. Following this industry-shaping template, Ro (formerly Roman) also fully exited the compounded GLP-1 market to focus entirely on branded medications, including Novo Nordisk’s offerings and Eli Lilly’s Zepbound.
Because Hims, Hers, and Ro have all transitioned to prescribing brand-name, FDA-approved metabolic treatments, choosing the right platform is no longer about finding the cheapest compounding pharmacy. Instead, the decision hinges on the level of clinical oversight, gender-focused medical integration, membership pricing tiers, and the robustness of each platform’s insurance concierge. In this comprehensive comparison, we analyze Hims, Ro, and Hers to determine which provider offers the best GLP-1 weight loss program for your health journey and budget in 2026.
Quick Comparison Table — 2026 Features & Costs
Before diving into the detailed clinical and financial breakdowns, here is an at-a-glance comparison of the three leading GLP-1 telehealth platforms as of mid-2026. All details, including pricing and medication offerings, have been verified to reflect current 2026 standards.
| Feature | Hims Weight Loss | Hers Weight Loss | Ro Body Program |
|---|---|---|---|
| Target Audience | Men | Women | All Genders |
| Membership Fee | $39 first month, then $149/mo | $39 first month, then $149/mo | $39 first month, then $149/mo (or $74/mo paid annually) |
| FDA Branded GLP-1s | Wegovy (Pen & Pill), Ozempic | Wegovy (Pen & Pill), Ozempic | Wegovy (Pen & Pill), Zepbound, Ozempic, Mounjaro, Foundayo |
| Compounded GLP-1s | No (Exited in early 2026) | No (Exited in early 2026) | No (Exited in early 2026) |
| Insurance Concierge | Basic coverage support | Basic coverage support | Comprehensive prior authorization advocacy |
| Starting Cash Cost | From $298/mo (Membership + low-dose oral Wegovy) | From $298/mo (Membership + low-dose oral Wegovy) | From $223/mo (Annual membership + low-dose oral Wegovy cash price) |
| Key Strength | Frictionless, fast digital portal for men | Holistic wellness and behavioral coaching for women | Outstanding insurance advocacy and medication variety |
Detailed Breakdown of Each GLP-1 Weight Loss Program
Hims Weight Loss
Hims has established a reputation for removing the friction associated with traditional healthcare, and its 2026 Weight Loss program for men continues this trend. Following the landmark March 2026 settlement with Novo Nordisk, Hims stopped offering unapproved compounded semaglutide to new patients. The company completely pivoted to providing legitimate access to branded medications. Today, the platform serves as a major digital storefront for Wegovy injections and Novo’s newly approved Wegovy oral pill.
Financially, the Hims weight loss model requires a dual-cost commitment. Patients pay a Hims Weight Loss Membership fee of $39 for the first month, which auto-renews at $149 per month thereafter. On top of this membership, patients pay for the medication itself. Thanks to its direct distribution agreement with Novo Nordisk, Hims offers brand-name Wegovy starting at cash-pay prices as low as $149 per month for the entry-level oral Wegovy pill, scaling up to $299 per month for the standard injectable Wegovy pens. This brings the minimum cash-pay total to roughly $298 per month, assuming a low-dose oral regimen.
Hims is highly optimized for efficiency. The intake process relies on an asynchronous, questionnaire-based assessment that a licensed provider reviews within 24 to 48 hours. There is no requirement for live video consultations or immediate, pre-treatment blood work. Approved medications are shipped directly to the patient’s door in discreet, temperature-controlled packaging. However, Hims does not offer a dedicated, high-touch insurance navigation service. If you plan to pay cash or have commercial insurance that already covers GLP-1s, Hims provides an incredibly smooth experience. Consumers should note that Hims is currently defending a July 2026 FTC lawsuit regarding data privacy and subscription billing transparency, which has prompted the platform to implement clearer cancellation pathways.
Hers Weight Loss
Hers, the sister brand to Hims, delivers a highly tailored metabolic health program designed explicitly for women. Like Hims, Hers completely transitioned away from compounded GLP-1 drugs following the 2026 regulatory shift. Instead, the platform offers women access to Novo Nordisk’s FDA-approved portfolio, pairing these cutting-edge therapies with gender-specific, holistic clinical care.
The pricing structure at Hers mirrors that of Hims. The platform charges a monthly membership fee of $149 (discounted to $39 for the first month). The cost of the prescribed medication is billed separately on top of this membership. Branded Wegovy oral pills start at $149 per month for starter doses, while injectable options begin around $299 per month. For women who are not medically eligible for GLP-1 medications or who are seeking lower-cost alternatives, Hers also offers personalized non-GLP-1 oral medication kits. These kits combine generic metabolic ingredients, such as bupropion and naltrexone, starting at $69 per month when paid upfront on a multi-month plan.
Where Hers shines is its clinical focus on the unique factors influencing women’s weight management, such as hormonal fluctuations, metabolic changes, and emotional eating habits. The Hers mobile app provides 24/7 care team messaging, lifestyle coaching, dietary guides, and mental wellness resources. While the platform lacks the aggressive, specialized insurance-fighting services found at Ro, its comprehensive digital ecosystem makes it a highly supportive option for women seeking an all-in-one metabolic health home.
Ro Body Program
The Ro Body program stands out in 2026 as the most clinically comprehensive and insurance-friendly telehealth weight loss portal on the market. Recognizing early that compounding was facing regulatory hurdles, Ro fully exited compounded GLP-1 therapies in early 2026. Instead, Ro focused on building deep, direct integrations with pharmaceutical manufacturers, notably linking with Eli Lilly’s LillyDirect service to offer streamlined access to Zepbound.
Ro’s membership structure is uniquely flexible. While the standard monthly Ro Body Membership is $149 per month (with the first month discounted to $39), patients can prepay for an annual membership, which slashes the ongoing cost to just $74 per month. Medication is billed separately. Branded Wegovy injections start at a cash price of $199 per month for starter doses (0.25 mg and 0.5 mg) during promotional windows, before stepping up to a standard $349 per month for higher maintenance doses. Branded Wegovy oral pills are priced from $149 to $299 per month. Zepbound KwikPens are available starting at $299 per month for low doses, rising to $449 per month for high maintenance strengths.
Ro’s absolute best feature is its dedicated Insurance Concierge. This specialized care team handles the tedious prior authorization process, interacting directly with commercial insurance companies to secure coverage for branded GLP-1s. If the concierge is successful, your medication cost can be reduced to a standard copay of $25 per month. When paired with the discounted annual membership, Ro represents the most cost-effective path to branded GLP-1 therapy for patients with qualifying insurance plans. Furthermore, Ro requires clinical accountability, including physician-ordered metabolic blood panels and scheduled check-ins to monitor health markers safely over the long term.
How to Choose the Best GLP-1 Program for You
Choosing between these three premium weight loss services requires analyzing your budget, insurance coverage, and personal clinical needs. In 2026, there is no single program that fits everyone, but clear patterns emerge depending on your situation.
Choose Hims if: You are a man looking for a highly efficient, direct, and private digital experience to obtain branded Wegovy or Ozempic. If you are paying entirely out-of-pocket and do not want to deal with the complexities of insurance claims, Hims offers a streamlined, questionnaire-only process that gets you prescribed and shipped your medication within days, without requiring video calls or immediate lab visits.
Choose Hers if: You are a woman seeking a comprehensive health home that treats weight loss through a holistic, gender-focused lens. Hers is the ideal choice if you want support that extends beyond the needle or pill, offering extensive nutritional guides, emotional support, and 24/7 care team access. It is also the best choice if you are interested in non-GLP-1 oral medication options as a starting point.
Choose Ro if: You have commercial health insurance and want a dedicated team of specialists to fight for coverage. Ro is also the clear choice if you want the widest selection of cutting-edge FDA-approved branded medications, including Eli Lilly’s Zepbound or the daily oral weight-loss pill Foundayo. If you prefer rigorous clinical monitoring, including metabolic lab tests, and want to lower your monthly telehealth program fees through annual prepay savings, Ro offers the highest overall value.
Frequently Asked Questions (FAQs)
Do Hims, Hers, or Ro still offer compounded semaglutide in 2026?
No. Following significant regulatory crackdowns by the FDA and a landmark legal settlement with Novo Nordisk in March 2026, Hims, Hers, and Ro have completely exited the compounded GLP-1 market. All three platforms now deal exclusively in FDA-approved, branded medications like Wegovy and Zepbound.
How does the insurance process differ between Ro and Hims/Hers?
Ro features an active, highly successful Insurance Concierge that works on behalf of the patient to secure prior authorizations, potentially dropping brand-name drug costs to a copay of $25 per month. Hims and Hers offer very basic coverage support, meaning they are primarily optimized for cash-paying patients or individuals who already have guaranteed commercial coverage.
What is the difference between injectable Wegovy and the Wegovy oral pill?
Both contain the active ingredient semaglutide. Injectable Wegovy is administered once a week via a subcutaneous pen. The Wegovy oral pill is a once-daily tablet that offers a needle-free alternative for individuals who dislike injections, though dosage pricing and absorption rates differ slightly.
Can I switch between programs if my needs change?
Yes. Because you are not locked into long-term clinical contracts (unless you opt for Ro’s discounted annual prepaid membership), you can cancel your subscription and transition to another platform if your clinical needs or financial situation shifts.
Verdict: The Best GLP-1 Weight Loss Program of 2026
In 2026, the telehealth weight loss market has matured, moving past the era of compound mixtures and embracing standardized, branded care. When comparing these three titans, the overall winner for the best GLP-1 program is the Ro Body Program.
While Hims and Hers excel at providing tailored, user-friendly digital spaces for men and women, respectively, Ro outclasses them in clinical depth and financial optimization. Ro’s dedicated Insurance Concierge is a massive financial advantage, transforming what could be a $1,000+ monthly cash-pay nightmare into an affordable insurance copay. Furthermore, Ro’s ability to offer Eli Lilly’s Zepbound via its LillyDirect integration—alongside the newest oral weight-loss daily pill, Foundayo—gives patients unparalleled medical flexibility. When you combine these factors with the ability to lower membership costs to $74 per month via their annual plan, Ro delivers the gold standard for telehealth metabolic care in 2026.
Prices and features mentioned are accurate as of the date of publication. Always check the official provider website for the most current pricing and availability.
